Literature DB >> 15185302

Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis.

Tea Restuccia1, Beatriz Gómez-Ansón, Mónica Guevara, Carlo Alessandria, Aldo Torre, M Elena Alayrach, Carlos Terra, Marta Martín, Magda Castellví, Lorena Rami, Aitor Sainz, Pere Ginès, Vicente Arroyo.   

Abstract

In advanced cirrhosis there is a reduction in the brain concentration of many organic osmolytes, particularly myo-inositol (MI). Hyponatremia could theoretically aggravate these changes as a result of hypo-osmolality of the extracellular fluid. The aim of this study was to determine the effects of hyponatremia on brain organic osmolytes and brain water content in cirrhosis. Brain organic osmolytes, measured by (1)H-magnetic resonance spectroscopy, and brain water content, as estimated by magnetization transfer ratio (MTR) and measurement of brain volume were determined in 14 patients with dilutional hyponatremia, 10 patients without hyponatremia, and eight healthy subjects. Patients with hyponatremia had remarkable lower levels of MI compared with values in nonhyponatremic patients and healthy subjects. Brain MI levels correlated directly with serum sodium and osmolality. Serum sodium was the only independent predictor of low brain MI levels. Serum sodium also correlated directly with other brain organic osmolytes, such as choline-containing compounds, creatine/phosphocreatine, and N-acetyl-aspartate. By contrast, brain glutamine/glutamate levels were higher in patients with cirrhosis compared with values in healthy subjects and correlated with plasma ammonia levels but not with serum sodium or osmolality. No significant differences were found in MTR values and cerebral volumes between patients with and without hyponatremia. In conclusion, dilutional hyponatremia in cirrhosis is associated with remarkable reductions in brain organic osmolytes that probably reflect compensatory osmoregulatory mechanisms against cell swelling triggered by a combination of high intracellular glutamine and low extracellular osmolality. These findings may be relevant to the pathogenesis of encephalopathy in hyponatremic patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185302     DOI: 10.1002/hep.20237

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Authors:  Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2015-08-08       Impact factor: 3.584

Review 2.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

Review 3.  Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence.

Authors:  Juan Córdoba; Rita García-Martinez; Macarena Simón-Talero
Journal:  Metab Brain Dis       Date:  2010-03-09       Impact factor: 3.584

Review 4.  Management of ascites and hepatorenal syndrome.

Authors:  Salvatore Piano; Marta Tonon; Paolo Angeli
Journal:  Hepatol Int       Date:  2017-08-23       Impact factor: 6.047

Review 5.  Renal dysfunction in patients with cirrhosis: Where do we stand?

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

6.  Inadvertent hyponatremia leading to acute cerebral edema and early evidence of herniation.

Authors:  Jessica Carpenter; Steve Weinstein; John Myseros; Gilbert Vezina; Michael J Bell
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

7.  In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage.

Authors:  Natalie M Zahr; Dirk Mayer; Shara Vinco; Juan Orduna; Richard Luong; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

Review 8.  The Changing Role of Sodium Management in Cirrhosis.

Authors:  Blanca Lizaola; Alan Bonder; Elliot B Tapper; Angela Mendez-Bocanegra; Andres Cardenas
Journal:  Curr Treat Options Gastroenterol       Date:  2016-06

9.  Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in-vivo proton MR spectroscopy.

Authors:  Vivek-A Saraswat; Sona Saksena; Kavindra Nath; Pranav Mandal; Jitesh Singh; M-Albert Thomas; Ramkishore-S Rathore; Rakesh-K Gupta
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

10.  Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.

Authors:  Vishwadeep Ahluwalia; James B Wade; Leroy Thacker; Kenneth A Kraft; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Iliana Bouneva; Puneet Puri; Velimir Luketic; Arun J Sanyal; Hochong Gilles; Douglas M Heuman; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2013-05-07       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.